Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Underreporting of hepatitis A in non-endemic countries: a systematic review and meta-analysis

Authors: Rachel D. Savage, Laura C. Rosella, Kevin A. Brown, Kamran Khan, Natasha S. Crowcroft

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

Information on reporting completeness of passive surveillance systems can improve the quality of and public health response to surveillance data and better inform public health planning. As a result, we systematically reviewed available literature on reporting completeness of hepatitis A in non-endemic countries.

Methods

We searched Medline, EMBASE and grey literature sources, restricting to studies published in English between 1997 and 21 May 2015. Primary studies on hepatitis A surveillance and underreporting in non-endemic countries were included, and assessed for risk of bias. A pooled proportion of reporting completeness was estimated using a DerSimonian-Laird random-effects model.

Results

Diagnosed hepatitis A cases identified through positive laboratory tests, physician visits, and inpatient hospital discharges were underreported to public health in all eight included studies. Reporting completeness ranged from 4 to 97 % (pooled proportion 59 %, 95 % confidence interval = 32 %, 84 %). Substantial heterogeneity was observed, which may be explained by differences in the referent data sources used to identify diagnosed cases and in case reporting mechanisms and/or staffing infrastructure. Completeness was improved in settings where case reporting was automated or where dedicated staff had clear reporting responsibilities.

Conclusions

Future studies that evaluate reporting completeness should describe the context, components, and operations of the surveillance system being evaluated in order to identify modifiable characteristics that improve system sensitivity and utility. Additionally, reporting completeness should be assessed across high risk groups to inform equitable allocation of public health resources and evaluate the effectiveness of targeted interventions.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization. WHO position paper on hepatitis A vaccines - June 2012. Wkly Epidemiol Rec. 2012;87:261–76. World Health Organization. WHO position paper on hepatitis A vaccines - June 2012. Wkly Epidemiol Rec. 2012;87:261–76.
2.
go back to reference Vrbova L, Johnson K, Whitfield Y, Middleton D. A descriptive study of reportable gastrointestinal illnesses in Ontario, Canada, from 2007 to 2009. BMC Public Health. 2012;12:970-2458-12-970.CrossRef Vrbova L, Johnson K, Whitfield Y, Middleton D. A descriptive study of reportable gastrointestinal illnesses in Ontario, Canada, from 2007 to 2009. BMC Public Health. 2012;12:970-2458-12-970.CrossRef
3.
go back to reference Ly KN, Klevens RM. Trends in disease and complications of hepatitis A virus infection in the United States, 1999–2011: a new concern for adults. J Infect Dis. 2015. doi:10.1093/infdis/jiu834. Ly KN, Klevens RM. Trends in disease and complications of hepatitis A virus infection in the United States, 1999–2011: a new concern for adults. J Infect Dis. 2015. doi:10.​1093/​infdis/​jiu834.
5.
go back to reference Advisory Committee on Immunization Practices (ACIP), Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-7):1–23. Advisory Committee on Immunization Practices (ACIP), Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-7):1–23.
6.
go back to reference Sane J, MacDonald E, Vold L, Gossner C, Severi E, Outbreak Investigation Team. Multistate foodborne hepatitis A outbreak among European tourists returning from Egypt--need for reinforced vaccination recommendations, November 2012 to April 2013. Euro Surveill. 2015;20:21018.CrossRefPubMed Sane J, MacDonald E, Vold L, Gossner C, Severi E, Outbreak Investigation Team. Multistate foodborne hepatitis A outbreak among European tourists returning from Egypt--need for reinforced vaccination recommendations, November 2012 to April 2013. Euro Surveill. 2015;20:21018.CrossRefPubMed
7.
go back to reference Swinkels HM, Kuo M, Embree G, Fraser Health Environmental Health Investigation Team, Andonov A, Henry B, et al. Hepatitis A outbreak in British Columbia, Canada: the roles of established surveillance, consumer loyalty cards and collaboration, February to May 2012. Euro Surveill. 2014;19:20792.CrossRefPubMed Swinkels HM, Kuo M, Embree G, Fraser Health Environmental Health Investigation Team, Andonov A, Henry B, et al. Hepatitis A outbreak in British Columbia, Canada: the roles of established surveillance, consumer loyalty cards and collaboration, February to May 2012. Euro Surveill. 2014;19:20792.CrossRefPubMed
8.
go back to reference Collier MG, Khudyakov YE, Selvage D, Adams-Cameron M, Epson E, Cronquist AJ, et al. Outbreak of hepatitis A in the USA associated with frozen pomegranate arils imported from Turkey: an epidemiological case study. Lancet Infect Dis. 2014;14:976–81.CrossRefPubMed Collier MG, Khudyakov YE, Selvage D, Adams-Cameron M, Epson E, Cronquist AJ, et al. Outbreak of hepatitis A in the USA associated with frozen pomegranate arils imported from Turkey: an epidemiological case study. Lancet Infect Dis. 2014;14:976–81.CrossRefPubMed
10.
go back to reference Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep. 1997;46(RR-10):1–55. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep. 1997;46(RR-10):1–55.
12.
go back to reference Doyle TJ, Glynn MK, Groseclose SL. Completeness of notifiable infectious disease reporting in the United States: an analytical literature review. Am J Epidemiol. 2002;155:866–74.CrossRefPubMed Doyle TJ, Glynn MK, Groseclose SL. Completeness of notifiable infectious disease reporting in the United States: an analytical literature review. Am J Epidemiol. 2002;155:866–74.CrossRefPubMed
13.
go back to reference Hadler SC, Webster HM, Erben JJ, Swanson JE, Maynard JE. Hepatitis A in day-care centers. A community-wide assessment. N Engl J Med. 1980;302:1222–7.CrossRefPubMed Hadler SC, Webster HM, Erben JJ, Swanson JE, Maynard JE. Hepatitis A in day-care centers. A community-wide assessment. N Engl J Med. 1980;302:1222–7.CrossRefPubMed
14.
go back to reference Klevens RM, Liu S, Roberts H, Jiles RB, Holmberg SD. Estimating acute viral hepatitis infections from nationally reported cases. Am J Public Health. 2014;104:482–7.CrossRefPubMedPubMedCentral Klevens RM, Liu S, Roberts H, Jiles RB, Holmberg SD. Estimating acute viral hepatitis infections from nationally reported cases. Am J Public Health. 2014;104:482–7.CrossRefPubMedPubMedCentral
15.
go back to reference Bonacic Marinovic A, Swaan C, van Steenbergen J, Kretzschmar M. Quantifying reporting timeliness to improve outbreak control. Emerg Infect Dis. 2015;21:209–16.CrossRefPubMed Bonacic Marinovic A, Swaan C, van Steenbergen J, Kretzschmar M. Quantifying reporting timeliness to improve outbreak control. Emerg Infect Dis. 2015;21:209–16.CrossRefPubMed
16.
go back to reference Kwong JC, Ratnasingham S, Campitelli MA, Daneman N, Deeks SL, Manuel DG, et al. The impact of infection on population health: results of the Ontario burden of infectious diseases study. PLoS One. 2012;7, e44103.CrossRefPubMedPubMedCentral Kwong JC, Ratnasingham S, Campitelli MA, Daneman N, Deeks SL, Manuel DG, et al. The impact of infection on population health: results of the Ontario burden of infectious diseases study. PLoS One. 2012;7, e44103.CrossRefPubMedPubMedCentral
17.
go back to reference Plass D, Mangen MJ, Kraemer A, Pinheiro P, Gilsdorf A, Krause G, et al. The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the burden of communicable diseases in Europe study. Epidemiol Infect. 2014;142:2024–35.CrossRefPubMed Plass D, Mangen MJ, Kraemer A, Pinheiro P, Gilsdorf A, Krause G, et al. The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the burden of communicable diseases in Europe study. Epidemiol Infect. 2014;142:2024–35.CrossRefPubMed
18.
go back to reference Alter MJ, Mares A, Hadler SC, Maynard JE. The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol. 1987;125:133–9.CrossRefPubMed Alter MJ, Mares A, Hadler SC, Maynard JE. The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol. 1987;125:133–9.CrossRefPubMed
19.
go back to reference Gibbons CL, Mangen MJ, Plass D, Havelaar AH, Brooke RJ, Kramarz P, et al. Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods. BMC Public Health. 2014;14:147-2458-14-147.CrossRef Gibbons CL, Mangen MJ, Plass D, Havelaar AH, Brooke RJ, Kramarz P, et al. Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods. BMC Public Health. 2014;14:147-2458-14-147.CrossRef
20.
go back to reference Keramarou M, Evans MR. Completeness of infectious disease notification in the United Kingdom: a systematic review. J Infect. 2012;64:555–64.CrossRefPubMed Keramarou M, Evans MR. Completeness of infectious disease notification in the United Kingdom: a systematic review. J Infect. 2012;64:555–64.CrossRefPubMed
21.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.CrossRefPubMedPubMedCentral
22.
go back to reference Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28:6653–7.CrossRefPubMed Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28:6653–7.CrossRefPubMed
23.
go back to reference Advisory Committee on Immunization Practices (ACIP). Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1999;48(RR-12):1–37. Advisory Committee on Immunization Practices (ACIP). Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1999;48(RR-12):1–37.
24.
go back to reference Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefPubMed Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefPubMed
25.
go back to reference Rosella LC, Bowman C, Pach B, Morgan S, Fitzpatrick T, Bornbaum C, et al. The development and validation of a meta-tool for quality appraisal of public health evidence: Meta Quality Appraisal Tool (MetaQAT), Proceedings of the Cochrane Canada Symposium 2015: May 21–22; Calgary, AB. 2015. Rosella LC, Bowman C, Pach B, Morgan S, Fitzpatrick T, Bornbaum C, et al. The development and validation of a meta-tool for quality appraisal of public health evidence: Meta Quality Appraisal Tool (MetaQAT), Proceedings of the Cochrane Canada Symposium 2015: May 21–22; Calgary, AB. 2015.
26.
go back to reference Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63:834–40.CrossRefPubMed Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63:834–40.CrossRefPubMed
29.
go back to reference German RR, Lee LM, Horan JM, Milstein RL, Pertowski CA, Waller MN, et al. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep. 2001;50(RR-13):1–35. quiz CE1-7.PubMed German RR, Lee LM, Horan JM, Milstein RL, Pertowski CA, Waller MN, et al. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep. 2001;50(RR-13):1–35. quiz CE1-7.PubMed
30.
go back to reference Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67:974–8.CrossRefPubMed Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67:974–8.CrossRefPubMed
31.
32.
go back to reference Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Books; 2008. p. 285–312. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Books; 2008. p. 285–312.
34.
go back to reference Backer HD, Bissell SR, Vugia DJ. Disease reporting from an automated laboratory-based reporting system to a state health department via local county health departments. Public Health Rep. 2001;116:257–65.CrossRefPubMedPubMedCentral Backer HD, Bissell SR, Vugia DJ. Disease reporting from an automated laboratory-based reporting system to a state health department via local county health departments. Public Health Rep. 2001;116:257–65.CrossRefPubMedPubMedCentral
35.
go back to reference Boehmer TK, Patnaik JL, Burnite SJ, Ghosh TS, Gershman K, Vogt RL. Use of hospital discharge data to evaluate notifiable disease reporting to Colorado’s Electronic Disease Reporting System. Public Health Rep. 2011;126:100–6.CrossRefPubMedPubMedCentral Boehmer TK, Patnaik JL, Burnite SJ, Ghosh TS, Gershman K, Vogt RL. Use of hospital discharge data to evaluate notifiable disease reporting to Colorado’s Electronic Disease Reporting System. Public Health Rep. 2011;126:100–6.CrossRefPubMedPubMedCentral
36.
go back to reference Centers for Disease Control and Prevention (CDC). Automated detection and reporting of notifiable diseases using electronic medical records versus passive surveillance--Massachusetts, June 2006-July 2007. MMWR - Morbidity & Mortality Weekly Report. 2008;57:373–6. Centers for Disease Control and Prevention (CDC). Automated detection and reporting of notifiable diseases using electronic medical records versus passive surveillance--Massachusetts, June 2006-July 2007. MMWR - Morbidity & Mortality Weekly Report. 2008;57:373–6.
37.
go back to reference Roels TH, Christl M, Kazmierczak JJ, MacKenzie WR, Davis JP. Hepatitis A infections in Wisconsin: trends in incidence and factors affecting surveillance, 1986–1995. WMJ. 1998;97:32–8.PubMed Roels TH, Christl M, Kazmierczak JJ, MacKenzie WR, Davis JP. Hepatitis A infections in Wisconsin: trends in incidence and factors affecting surveillance, 1986–1995. WMJ. 1998;97:32–8.PubMed
38.
go back to reference Simmons G, Whittaker R, Boyle K, Morris AJ, Upton A, Calder L. Could laboratory-based notification improve the control of foodborne illness in New Zealand? N Z Med J. 2002;115:237–40.PubMed Simmons G, Whittaker R, Boyle K, Morris AJ, Upton A, Calder L. Could laboratory-based notification improve the control of foodborne illness in New Zealand? N Z Med J. 2002;115:237–40.PubMed
39.
go back to reference Overhage JM, Grannis S, McDonald CJ. A comparison of the completeness and timeliness of automated electronic laboratory reporting and spontaneous reporting of notifiable conditions. Am J Public Health. 2008;98:344–50.CrossRefPubMedPubMedCentral Overhage JM, Grannis S, McDonald CJ. A comparison of the completeness and timeliness of automated electronic laboratory reporting and spontaneous reporting of notifiable conditions. Am J Public Health. 2008;98:344–50.CrossRefPubMedPubMedCentral
40.
go back to reference Matin N, Grant A, Granerod J, Crowcroft N. Hepatitis A surveillance in England--how many cases are not reported and does it really matter? Epidemiology & Infection. 2006;134:1299–302.CrossRef Matin N, Grant A, Granerod J, Crowcroft N. Hepatitis A surveillance in England--how many cases are not reported and does it really matter? Epidemiology & Infection. 2006;134:1299–302.CrossRef
41.
go back to reference Sickbert-Bennett EE, Weber DJ, Poole C, MacDonald PD, Maillard JM. Completeness of communicable disease reporting, North Carolina, USA, 1995–1997 and 2000–2006. Emerg Infect Dis. 2011;17:23–9.CrossRefPubMedPubMedCentral Sickbert-Bennett EE, Weber DJ, Poole C, MacDonald PD, Maillard JM. Completeness of communicable disease reporting, North Carolina, USA, 1995–1997 and 2000–2006. Emerg Infect Dis. 2011;17:23–9.CrossRefPubMedPubMedCentral
43.
go back to reference Abbott DD. Architect System - HAVAb-IgM, Product Monograph. 2004. Abbott DD. Architect System - HAVAb-IgM, Product Monograph. 2004.
Metadata
Title
Underreporting of hepatitis A in non-endemic countries: a systematic review and meta-analysis
Authors
Rachel D. Savage
Laura C. Rosella
Kevin A. Brown
Kamran Khan
Natasha S. Crowcroft
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1636-6

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue